[Neonatal screening for mucoviscidosis using the BM-test-meconium].
In the Federal Republic of Germany screening for cystic fibrosis by the albumin content of meconium (BM-test) is performed on most newborns. In this paper arguments for and against this test are discussed. Arguments in favour of BM-test-screening are the possibility of early diagnosis, early treatment and genetic counseling. Drawbacks of the test are false positive and false negative results. The authors conclude that this screening test should not be performed.
D003550:Cystic Fibrosis / Q000175:diagnosis*; D005188:False Negative Reactions; D005189:False Positive Reactions; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000175:diagnosis*; D008470:Meconium / Q000032:analysis*; D011934:Reagent Strips; D012709:Serum Albumin / Q000032:analysis
D011934:Reagent Strips; D012709:Serum Albumin
Neugeborenen-Screening auf Mucoviscidose mit dem BM-Test-Meconium.